tiprankstipranks
Trending News
More News >
Brainsway (IL:BWAY)
:BWAY

Brainsway (BWAY) Price & Analysis

Compare
0 Followers

BWAY Stock Chart & Stats


Financials

BWAY FAQ

What was Brainsway ’s price range in the past 12 months?
Brainsway lowest stock price was 1090.00 and its highest was 2359.00 in the past 12 months.
    What is Brainsway ’s market cap?
    Brainsway ’s market cap is 835.64M.
      When is Brainsway ’s upcoming earnings report date?
      Brainsway ’s upcoming earnings report date is Aug 06, 2025 which is in 28 days.
        How were Brainsway ’s earnings last quarter?
        Brainsway released its earnings results on May 13, 2025. The company reported 10.6 earnings per share for the quarter, beating the consensus estimate of N/A by 10.6.
          Is Brainsway overvalued?
          According to Wall Street analysts Brainsway ’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Brainsway pay dividends?
            Brainsway does not currently pay dividends.
            What is Brainsway ’s EPS estimate?
            Brainsway ’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Brainsway have?
            Brainsway has 37,794,865 shares outstanding.
              What happened to Brainsway ’s price movement after its last earnings report?
              Brainsway reported an EPS of 10.6 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 8.822%.
                Which hedge fund is a major shareholder of Brainsway ?
                Currently, no hedge funds are holding shares in IL:BWAY

                Company Description

                Brainsway

                Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company primarily serves doctors, hospitals, and medical centers in the field of psychiatry. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.

                BWAY Earnings Call

                Q1 2025
                0:00 / 0:00
                Earnings Call Sentiment|Positive
                BrainsWay's earnings call highlighted strong revenue growth and an increase in system shipments, alongside advancements in clinical trials and positive cash flow. However, these positives were countered by increased operating expenses and ongoing monitoring of geopolitical and tariff risks.Read More>
                Similar Stocks
                Company
                Price & Change
                Follow
                Elbit Imaging
                Ilex Medical
                Epitomee Med
                Sofwave
                Pulsenmore
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis